Deglycase-activity oriented screening to identify DJ-1 inhibitors

Area of Science:

• Biochemistry
• Enzymology
• Drug Discovery

Background:

• DJ-1/PARK7 is an oncoprotein and Parkinson's disease-associated enzyme with deglycase activity.
• Its catalytic site (Cys106) is a target for inhibitors, but suitable ones are lacking.
• Understanding DJ-1's enzymatic functions is key for therapeutic development.

Purpose of the Study:

• To develop and optimize assays for evaluating DJ-1's deglycase and esterase activities.
• To screen a library of potential DJ-1 inhibitors using these novel assays.
• To establish a platform for discovering anti-cancer drugs targeting DJ-1.

Main Methods:

• Enzyme-coupled, fluorescence lactate-detection assay for DJ-1 deglycase activity.
• Colorimetric and fluorescent substrate assays for DJ-1 esterase activity.
• Screening of reversible and irreversible DJ-1 inhibitors.

Main Results:

• Optimized assays successfully evaluated DJ-1's deglycase and esterase activities.
• A library of potential DJ-1 inhibitors was screened.
• The study established a deglycase activity-oriented screening platform.

Conclusions:

• The developed assays provide a robust method for DJ-1 inhibitor screening.
• This platform facilitates the discovery of novel anti-cancer agents targeting DJ-1.
• The findings advance the understanding of DJ-1's enzymatic roles and therapeutic potential.